1. Home
  2. NCNA vs CELZ Comparison

NCNA vs CELZ Comparison

Compare NCNA & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NuCana plc

NCNA

NuCana plc

N/A

Current Price

$1.32

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

N/A

Current Price

$0.87

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCNA
CELZ
Founded
1997
1998
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
7.5M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
NCNA
CELZ
Price
$1.32
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
61.2K
536.2K
Earning Date
06-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.08
EPS
N/A
N/A
Revenue
N/A
$6,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.21
$0.62
52 Week High
$7.01
$6.25

Technical Indicators

Market Signals
Indicator
NCNA
CELZ
Relative Strength Index (RSI) 38.31 34.55
Support Level $1.21 $0.80
Resistance Level $1.41 $0.93
Average True Range (ATR) 0.09 0.07
MACD -0.02 -0.03
Stochastic Oscillator 0.00 0.53

Price Performance

Historical Comparison
NCNA
CELZ

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: